Harvard Bioscience Inc
F:HBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Harvard Bioscience Inc
F:HBI
|
US |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
B
|
Balchem Corp
F:BL9B
|
US |
|
Y
|
Yolo Group SpA
MIL:YOLO
|
IT |
|
L
|
LPL Financial Holdings Inc
XBER:7LI
|
US |
|
S
|
Springer Nature AG & Co KgaA
F:SPG
|
DE |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
O
|
Occidental Petroleum Corp
SWB:OPC
|
US |
|
P
|
Pacific Biosciences of California Inc
SWB:P09
|
US |
|
S
|
Societe Generale SA
F:SGE
|
FR |
|
C
|
CarGurus Inc
F:0C6
|
US |
|
O
|
Odfjell Drilling Ltd
XMUN:OD3
|
BM |
|
S
|
Sompo Holdings Inc
XBER:ANK
|
JP |
|
Murray & Roberts Holdings Ltd
F:LDYA
|
ZA |
|
C
|
Compagnie de Saint Gobain SA
SIX:GOB
|
FR |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
K
|
Kikkoman Corp
F:KIK
|
JP |
|
O
|
Occidental Petroleum Corp
XBER:OPC
|
US |
|
C
|
China Securities Co Ltd
SWB:CS0
|
CN |
Wall St Price Targets
HBI Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBI is 3.93 EUR with a low forecast of 3.89 EUR and a high forecast of 4.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HBI's stock price target?
Price Target
3.93
EUR
According to Wall Street analysts, the average 1-year price target for
HBI is 3.93 EUR with a low forecast of 3.89 EUR and a high forecast of 4.04 EUR.
What is the Revenue forecast for Harvard Bioscience Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 2 years is 6%.
What is the Gross Profit forecast for Harvard Bioscience Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is 8%.